You have 9 free searches left this month | for more free features.

Dosing strategy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Personalized Dosing Strategy of Patients Treated by Carbapenems:

Recruiting
  • Bacterial Infections
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Mar 13, 2023

    NSCLC, Glioblastoma Multiforme Trial in United States (GLR2007)

    Completed
    • Non-small Cell Lung Cancer
    • Glioblastoma Multiforme
    • Lafayette, Indiana
    • +3 more
    Dec 21, 2022

    Teicoplanin in Intensive Care and Haematology Patients

    Completed
    • Bacterial Infections
    • No intervention
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Jan 30, 2023

    Crohn Disease Trial in Cincinnati (RoadMAB)

    Recruiting
    • Crohn Disease
    • RoadMAB
    • Cincinnati, Ohio
      Cincinnati Children's Hospital
    Oct 19, 2021

    Medication Errors Trial in United States (New Labeling/Dosing Strategy)

    Active, not recruiting
    • Medication Errors
    • New Labeling/Dosing Strategy
    • Stanford, California
    • +3 more
    Oct 12, 2021

    Gram-Negative Infections Trial in Cairo (Piperacillin/Tazobactam Continuous infusion, Piperacillin/Tazobactam Intermittent

    Completed
    • Gram-Negative Infections
    • Piperacillin/Tazobactam Continuous infusion
    • Piperacillin/Tazobactam Intermittent infusion
    • Cairo, Egypt
      Cairo University Hospitals
    May 18, 2021

    Hematopoietic Stem Cell Transplantation Trial in Seoul (Mycophenolate Mofetil)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Mycophenolate Mofetil
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 29, 2021

    End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)

    Recruiting
    • End Stage Renal Disease on Dialysis
    • novel artificial intelligence assisted platform
    • Kaohsiung,, Taiwan
      Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
    Oct 5, 2021

    Intensive Care Unit, Postoperative Care Trial in Seoul (Dexmedetomidine Hydrochloride)

    Completed
    • Intensive Care Unit
    • Postoperative Care
    • Dexmedetomidine Hydrochloride
    • Seoul, Jongro Gu, Korea, Republic of
      Seoul National University Hospital
    Apr 13, 2020

    Atrial Fibrillation Trial in Valencia (other, device, drug)

    Completed
    • Atrial Fibrillation
    • Conventional cryotherapy dosage
    • +4 more
    • Valencia, Spain
      Hospital Clínico Universitario de Valencia
    Aug 14, 2019

    Osteogenesis Imperfecta Trial in Worldwide (Setrusumab, Placebo)

    Recruiting
    • Osteogenesis Imperfecta
    • Setrusumab
    • Placebo
    • Little Rock, Arkansas
    • +44 more
    Jan 26, 2023

    Pneumonia Trial in Rochester (Dexamethasone)

    Not yet recruiting
    • Pneumonia
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 12, 2022

    Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine

    Not yet recruiting
    • Breast Cancer
    • Standard of care administration of Endocrine therapy
    • Dose-frequency escalation administration of Endocrine therapy
    • (no location specified)
    Feb 22, 2023

    Healthy, Psychedelic Experiences, Sleep Trial in Madison (Psilocybin and Saline)

    Not yet recruiting
    • Healthy
    • +2 more
    • Psilocybin and Saline
    • Madison, Wisconsin
      University of Wisconsin Hospital and Clinics
    Jan 23, 2023

    Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)

    Recruiting
    • Obesity
    • Immune Deficiency
    • Institutional standard intravenous immune globulin treatment
    • Somerville, New Jersey
      Robert Wood Johnson University Hospital Somerset
    Oct 10, 2022

    Choroidal Neovascularization Trial in Guangzhou (0.5mg intravitreal ranibizumab)

    Completed
    • Choroidal Neovascularization
    • 0.5mg intravitreal ranibizumab
    • Guangzhou, Guangdong, China
      ZhongShan Ophthalmic Center, Sun Yat-sen University
    Mar 7, 2019

    Spinae Erector Block and Gabapentin on Recovery and Length of

    Active, not recruiting
    • Adolescent Idiopathic Scoliosis
    • gabapentin + bilateral spine erector block
    • Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
      Hospital Italiano de Buenos Aires
    Oct 21, 2023

    Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)

    Not yet recruiting
    • Sickle Cell Anemia in Children
    • Sickle Cell Disease
    • Luanda, Angola
      Hospital Geral dos Cajueiros
    Jan 26, 2023

    Vitamin D Deficiency, Critical Illness Trial in Taipei (Vitamin D, Medium Chain Triglycerides)

    Not yet recruiting
    • Vitamin D Deficiency
    • Critical Illness
    • Vitamin D
    • Medium Chain Triglycerides
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jun 30, 2023

    Colorectal Cancer Metastatic Trial in France (Regorafenib)

    Recruiting
    • Colorectal Cancer Metastatic
    • Brest, France
    • +11 more
    Dec 7, 2022

    IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • Infliximab
    • Adalimumab
    • Gent, Belgium
    • +6 more
    May 17, 2022

    Aging, Sarcopenia, Muscle Atrophy Trial in Stirling (Fish oil supplementation)

    Recruiting
    • Aging
    • +2 more
    • Fish oil supplementation
    • Stirling, Stirlingshire, United Kingdom
      University of Stirling
    May 16, 2022

    Kidney Calculi, Crohn's Disease Trial in Vancouver (Calcium Carbonate)

    Recruiting
    • Kidney Calculi
    • Crohn's Disease
    • Calcium Carbonate
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    May 16, 2022

    IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

    Recruiting
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • HS-10390 tablet
    • Placebo tablet
    • Nanjing, Jiangsu, China
      Zhongda Hospital, Affiliated to Southeast University
    Jul 12, 2023